Institute of Biology and Medical Sciences, Soochow University;
Unit of Immune Signaling and Regulation, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences;
Unit of Vaccinology and Anti-viral Strategies, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences;
Unit of Tumor Virology, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai,Chinese Academy of Sciences;
Institute of Pathogenic Biology, University of South China;
Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences;
State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences;
Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation;
Vaccine Center, Institut Pasteur of Shanghai, Chinese Academy of Sciences;
Toll-like receptor(TLR) mTOR vaccine hepatitis B virus(HBV) hepatitis C virus(HCV) adjuvant c-fos;